Cubist Systematic Strategies LLC Boosts Stake in HealthStream, Inc. (NASDAQ:HSTM)

Cubist Systematic Strategies LLC boosted its stake in HealthStream, Inc. (NASDAQ:HSTM) by 33.1% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 54,419 shares of the technology company’s stock after buying an additional 13,536 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.18% of HealthStream worth $1,518,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in HealthStream by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 2,938,685 shares of the technology company’s stock valued at $78,345,000 after buying an additional 31,943 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in HealthStream by 1.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,570,735 shares of the technology company’s stock valued at $43,824,000 after buying an additional 15,379 shares in the last quarter. First Eagle Investment Management LLC lifted its stake in HealthStream by 7.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 530,178 shares of the technology company’s stock valued at $14,792,000 after buying an additional 35,350 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in HealthStream by 2.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 199,775 shares of the technology company’s stock valued at $5,400,000 after buying an additional 5,367 shares in the last quarter. Finally, Hillsdale Investment Management Inc. lifted its stake in HealthStream by 8.7% in the 1st quarter. Hillsdale Investment Management Inc. now owns 188,881 shares of the technology company’s stock valued at $5,036,000 after buying an additional 15,150 shares in the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.

Insider Transactions at HealthStream

In related news, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now directly owns 9,527 shares in the company, valued at approximately $267,041.81. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now owns 22,326 shares of the company’s stock, valued at $636,960.78. The disclosure for this sale can be found here. Insiders own 20.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HSTM. Canaccord Genuity Group increased their price target on HealthStream from $27.00 to $28.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. StockNews.com lowered HealthStream from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $30.00.

HealthStream Stock Up 1.4 %

Shares of HealthStream stock opened at $29.25 on Wednesday. The firm has a market cap of $889.14 million, a PE ratio of 50.43, a P/E/G ratio of 4.25 and a beta of 0.36. The business’s fifty day moving average is $28.61 and its two-hundred day moving average is $27.56. HealthStream, Inc. has a fifty-two week low of $21.49 and a fifty-two week high of $31.15.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Monday, July 22nd. The technology company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.02. The business had revenue of $71.56 million during the quarter, compared to the consensus estimate of $72.85 million. HealthStream had a return on equity of 5.19% and a net margin of 6.26%. The business’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.13 EPS. Equities research analysts anticipate that HealthStream, Inc. will post 0.56 EPS for the current year.

HealthStream Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Stockholders of record on Monday, August 5th were issued a dividend of $0.028 per share. The ex-dividend date was Monday, August 5th. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.38%. HealthStream’s payout ratio is 18.97%.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.